Surgical Robotics Technology
Global medical technology business, Smith+Nephew, has announced that it has completed the acquisition of the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation for $240 million.
The acquisition supports Smith+Nephew’s strategy to invest in higher-growth segments. It will significantly strengthen Smith+Nephew’s extremities business by adding a combination of a focused sales channel, complementary shoulder replacement and upper and lower extremities portfolio, and an exciting new product pipeline. This includes a next-generation shoulder replacement system, which is expected to be ready for full commercial launch in 2022.
Skip Kiil, President, Global Orthopaedics at Smith+Nephew, said:
“We are excited to secure this established global business in the rapidly growing extremities segment. Its portfolio, specialised sales channel and product pipeline all strengthen our business and we look forward to welcoming our new colleagues to Smith+Nephew.”
